Haaskjold, Yngvar Lunde
Bjørneklett, Rune
Bostad, Leif
Bostad, Lars Sigurd
Lura, Njål Gjærde
Knoop, Thomas
Article History
Received: 27 July 2021
Accepted: 23 December 2021
First Online: 11 January 2022
Declarations
:
: The study was approved by the Western Norwegian Regional Committee for Medical and Health Research Ethics (Reference no. 2018/2130). All the study participants provided informed consent. The research was done according to the Declaration of Helsinki.
: Not Applicable.
: Thomas Knoop has been principal investigator and Yngvar Lunde Haaskjold has been.sub-investigator for the Novartis LNP023X2203/APPLAUSE-IgAN trial at Haukeland University Hospital. The remaining authors declare that they have no competing interests.